PAH Stories from the Heart: Patient Testimonials
We learned more about patients with pulmonary arterial hypertension (PAH) by listening to their compelling stories. These videos were shown at an internal meeting to encourage Merck employees to keep forging ahead to get WINREVAIR, a drug for this rare disease, approved by the FDA.